{"id":"glucose-insulin-potassium","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypokalemia"},{"rate":null,"effect":"Fluid overload"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The GIK regimen enhances cardiac energy metabolism by promoting glucose uptake and utilization in ischemic myocardium while the potassium component helps maintain cellular electrolyte balance and reduce arrhythmias. This metabolic support reduces infarct size and improves cardiac function recovery in the setting of acute myocardial infarction or cardiac stress.","oneSentence":"Glucose-Insulin-Potassium (GIK) therapy delivers glucose, insulin, and potassium together to improve myocardial metabolism and reduce ischemic injury during acute cardiac events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:14:12.659Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction"},{"name":"Cardiac protection during ischemic events"}]},"trialDetails":[{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":"Acute Aluminum Phosphide Poisoned Cases","enrollment":74},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT07389837","phase":"NA","title":"Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2026-02-01","conditions":"Exercise, Endurance Cycling Performance, Carbohydrate Intolerance","enrollment":32},{"nctId":"NCT05353322","phase":"NA","title":"Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health","status":"RECRUITING","sponsor":"Columbia University","startDate":"2022-06-30","conditions":"Sedentary Behavior, Cardiometabolic Risk Factors, Blood Pressure","enrollment":324},{"nctId":"NCT02054429","phase":"PHASE1","title":"Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2013-01","conditions":"Ischemic Stroke","enrollment":30},{"nctId":"NCT03305549","phase":"NA","title":"Recovery After Dialysis-Requiring Acute Kidney Injury","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2017-09-29","conditions":"Acute Kidney Injury","enrollment":16},{"nctId":"NCT05627479","phase":"PHASE2","title":"MAGIK for Femoral/Tibial Shaft Fractures","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2024-12-01","conditions":"Femoral Shaft Fracture, Tibial Shaft Fracture","enrollment":""},{"nctId":"NCT06724991","phase":"NA","title":"Lower Vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency Department","status":"NOT_YET_RECRUITING","sponsor":"University of Malaya","startDate":"2025-01-01","conditions":"Hyperkalemia","enrollment":50},{"nctId":"NCT06094998","phase":"","title":"Health Status of Children Born After Assisted Reproductive Technologies","status":"COMPLETED","sponsor":"Kazakhstan's Medical University \"KSPH\"","startDate":"2023-10-18","conditions":"Children Born After Assisted Reproductive Technologies, Health Status, Child Development","enrollment":252},{"nctId":"NCT05464966","phase":"NA","title":"The Primary Objective of This Study Was to Investigate the Effect of Insulin on Myocardial Perfusion and Cardiac Function in Patients Undergoing Cardiac Surgery for CPB Using Transesophageal Echocardiography (TEE) to Detect CSBF","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2022-06-01","conditions":"Insulin","enrollment":74},{"nctId":"NCT02036372","phase":"NA","title":"Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-01","conditions":"Diabetes Mellitus Type II","enrollment":150},{"nctId":"NCT05729100","phase":"NA","title":"The Effects of Carbohydrate-electrolyte Solution on Metabolic Responses in Paediatric Patients","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2023-01-01","conditions":"Fasting","enrollment":110},{"nctId":"NCT00823108","phase":"PHASE1","title":"Rapid Administration of Insulin in Sepsis","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2009-03","conditions":"Septic Shock","enrollment":20},{"nctId":"NCT02930044","phase":"NA","title":"Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2016-10","conditions":"Diabetic Ketoacidosis","enrollment":18},{"nctId":"NCT03519217","phase":"","title":"Genetic Study for Infantile Onset Diabetes Mellitus","status":"UNKNOWN","sponsor":"Shimaa Kamal","startDate":"2020-06-05","conditions":"Gene Mutation in Infantile Onset Diabetes Mellitus","enrollment":60},{"nctId":"NCT00882050","phase":"PHASE1, PHASE2","title":"Intravenous Exenatide (Byetta) During Surgery","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2009-03","conditions":"Euglycemia, Hypoglycemia, Hyperglycemia","enrollment":104},{"nctId":"NCT02866435","phase":"EARLY_PHASE1","title":"Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2016-11","conditions":"Hypoglycemia","enrollment":27},{"nctId":"NCT03337477","phase":"PHASE2","title":"A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-02-13","conditions":"Hyperkalemia","enrollment":70},{"nctId":"NCT02590016","phase":"PHASE4","title":"Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Tampere University Hospital","startDate":"2015-09","conditions":"Gestational Diabetes, Hypoglycemia, Neonatal","enrollment":50},{"nctId":"NCT02652975","phase":"NA","title":"Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2015-09","conditions":"Breast Neoplasms, Endothelial Dysfunction, Cardiovascular Disease","enrollment":76},{"nctId":"NCT01187329","phase":"NA","title":"The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2010-10","conditions":"Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis","enrollment":100},{"nctId":"NCT00675987","phase":"PHASE4","title":"A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2007-05","conditions":"Obesity, Hypertension, Hyperglycemia","enrollment":53},{"nctId":"NCT03522181","phase":"NA","title":"Glucose-insulin-potassium Therapy Improves Lactic Acidosis in Liver Transplantation","status":"COMPLETED","sponsor":"Central South University","startDate":"2016-02","conditions":"Liver Transplantation","enrollment":80},{"nctId":"NCT02236598","phase":"PHASE2","title":"The Effects of Potassium on Glucose Metabolism in African Americans","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-01","conditions":"Borderline Hypokalemia","enrollment":61},{"nctId":"NCT00965406","phase":"PHASE3","title":"Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2010-08","conditions":"Acute Coronary Syndrome","enrollment":772},{"nctId":"NCT02305199","phase":"NA","title":"Hartmann's Solution and Normal Saline in Type II Diabetes Patients","status":"WITHDRAWN","sponsor":"Yeungnam University College of Medicine","startDate":"2015-01-01","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT00788242","phase":"NA","title":"The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Christoph Ellenberger","startDate":"2009-01","conditions":"Aortic Stenosis, Coronary Heart Disease, Heart Failure","enrollment":200},{"nctId":"NCT00091507","phase":"PHASE3","title":"IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2006-11","conditions":"Angina, Unstable, Cardiovascular Diseases, Heart Diseases","enrollment":911},{"nctId":"NCT01921374","phase":"NA","title":"Mother-caregivers of Children With Duchenne Muscular Dystrophy","status":"COMPLETED","sponsor":"Monica Levy Andersen","startDate":"2013-08","conditions":"Other Diseases or Conditions","enrollment":60},{"nctId":"NCT01225159","phase":"NA","title":"Tight Glycaemic Control During Cardiac Surgery","status":"TERMINATED","sponsor":"Prince of Songkla University","startDate":"2008-09","conditions":"Nosocomial Infection, External Causes of Morbidity and Mortality, Hypoglycemia","enrollment":200},{"nctId":"NCT02591927","phase":"PHASE3","title":"Reappraisal of GIK in Acute STEMI by Pre-hospital Administration","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2016-02","conditions":"Myocardial Infarction","enrollment":334},{"nctId":"NCT01516138","phase":"PHASE2","title":"Benefits of GIK in Cardiac Surgery Patients","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2012-02","conditions":"Cardiac Surgery, Cardiopulmonary Bypass","enrollment":930},{"nctId":"NCT01825720","phase":"NA","title":"Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2013-03","conditions":"Valvular Heart Disease","enrollment":106},{"nctId":"NCT00998465","phase":"","title":"Hemodynamics, Salt Sensitivity and Body Composition in Patients With Morbid Obesity","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2009-11","conditions":"Obesity, Hypertension","enrollment":36},{"nctId":"NCT01384656","phase":"PHASE4","title":"Effect of Glucose-insulin-potassium Solution on Myocardial Protection During Off-pump Coronary Bypass Surgery in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2011-02","conditions":"Acute Coronary Syndrome","enrollment":66},{"nctId":"NCT00282867","phase":"PHASE2","title":"Glucose Regulation in Acute Stroke Patients (GRASP) Study","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2006-05","conditions":"Stroke, Hyperglycemia","enrollment":74},{"nctId":"NCT00899483","phase":"NA","title":"Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?","status":"UNKNOWN","sponsor":"University Hospital Birmingham","startDate":"2009-07","conditions":"Type 2 Diabetes","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":548,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["GIK"],"phase":"phase_3","status":"active","brandName":"Glucose-Insulin-Potassium","genericName":"Glucose-Insulin-Potassium","companyName":"Centre Hospitalier Universitaire Vaudois","companyId":"centre-hospitalier-universitaire-vaudois","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucose-Insulin-Potassium (GIK) therapy delivers glucose, insulin, and potassium together to improve myocardial metabolism and reduce ischemic injury during acute cardiac events. Used for Acute myocardial infarction, Cardiac protection during ischemic events.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}